Global Exosome Detection and Diagnosis Market Research Report 2024

Exosome Detection and Diagnosis Market

Exosomes are small extracellular vesicles released by various cells into the extracellular space. They contain proteins, lipids, and nucleic acids, playing a role in intercellular communication.

The global Exosome Detection and Diagnosis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Exosome Detection and Diagnosis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Exosome Detection and Diagnosis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Exosome Detection and Diagnosis in Cancers is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Exosome Detection and Diagnosis include Thermo Fisher Scientific, Bio-Techne, System Biosciences, QIAGEN, Lonza, NX Pharmagen, NanoSomiX, Miltenyi Biotech and Norgen Biotek, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Exosome Detection and Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exosome Detection and Diagnosis.

Report Scope

The Exosome Detection and Diagnosis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Exosome Detection and Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Exosome Detection and Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Thermo Fisher Scientific

Bio-Techne

System Biosciences

QIAGEN

Lonza

NX Pharmagen

NanoSomiX

Miltenyi Biotech

Norgen Biotek

AMSBio

Aethlon Medical

Anjarium Biosciences

Ciloa

InnovaPrep

Creative Medical Technologies

ILIAS Biologics

Unchained Labs

Rion

Cell Guidance System

INOVIQ

Danaher

Exopharm

Everzom

RoosterBio

Creative Biolabs

Kits & Reagents

Instruments

Services

Cancers

Neurodegenerative Diseases

Cardiovascular Diseases

Infectious Diseases

Other

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Scope of Exosome Detection and Diagnosis Market Report

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Exosome Detection and Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Exosome Detection and Diagnosis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Kits & Reagents

1.2.3 Instruments

1.2.4 Services

1.3 Market by Application

1.3.1 Global Exosome Detection and Diagnosis Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Cancers

1.3.3 Neurodegenerative Diseases

1.3.4 Cardiovascular Diseases

1.3.5 Infectious Diseases

1.3.6 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Exosome Detection and Diagnosis Market Perspective (2019-2030)

2.2 Exosome Detection and Diagnosis Growth Trends by Region

2.2.1 Global Exosome Detection and Diagnosis Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Exosome Detection and Diagnosis Historic Market Size by Region (2019-2024)

2.2.3 Exosome Detection and Diagnosis Forecasted Market Size by Region (2025-2030)

2.3 Exosome Detection and Diagnosis Market Dynamics

2.3.1 Exosome Detection and Diagnosis Industry Trends

2.3.2 Exosome Detection and Diagnosis Market Drivers

2.3.3 Exosome Detection and Diagnosis Market Challenges

2.3.4 Exosome Detection and Diagnosis Market Restraints

3.1 Global Top Exosome Detection and Diagnosis Players by Revenue

3.1.1 Global Top Exosome Detection and Diagnosis Players by Revenue (2019-2024)

3.1.2 Global Exosome Detection and Diagnosis Revenue Market Share by Players (2019-2024)

3.2 Global Exosome Detection and Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Exosome Detection and Diagnosis Revenue

3.4 Global Exosome Detection and Diagnosis Market Concentration Ratio

3.4.1 Global Exosome Detection and Diagnosis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Exosome Detection and Diagnosis Revenue in 2023

3.5 Exosome Detection and Diagnosis Key Players Head office and Area Served

3.6 Key Players Exosome Detection and Diagnosis Product Solution and Service

3.7 Date of Enter into Exosome Detection and Diagnosis Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Exosome Detection and Diagnosis Historic Market Size by Type (2019-2024)

4.2 Global Exosome Detection and Diagnosis Forecasted Market Size by Type (2025-2030)

5.1 Global Exosome Detection and Diagnosis Historic Market Size by Application (2019-2024)

5.2 Global Exosome Detection and Diagnosis Forecasted Market Size by Application (2025-2030)

6.1 North America Exosome Detection and Diagnosis Market Size (2019-2030)

6.2 North America Exosome Detection and Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Exosome Detection and Diagnosis Market Size by Country (2019-2024)

6.4 North America Exosome Detection and Diagnosis Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7.1 Europe Exosome Detection and Diagnosis Market Size (2019-2030)

7.2 Europe Exosome Detection and Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Exosome Detection and Diagnosis Market Size by Country (2019-2024)

7.4 Europe Exosome Detection and Diagnosis Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Exosome Detection and Diagnosis Market Size (2019-2030)

8.2 Asia-Pacific Exosome Detection and Diagnosis Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Exosome Detection and Diagnosis Market Size by Region (2019-2024)

8.4 Asia-Pacific Exosome Detection and Diagnosis Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Exosome Detection and Diagnosis Market Size (2019-2030)

9.2 Latin America Exosome Detection and Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Exosome Detection and Diagnosis Market Size by Country (2019-2024)

9.4 Latin America Exosome Detection and Diagnosis Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Exosome Detection and Diagnosis Market Size (2019-2030)

10.2 Middle East & Africa Exosome Detection and Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Exosome Detection and Diagnosis Market Size by Country (2019-2024)

10.4 Middle East & Africa Exosome Detection and Diagnosis Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Detail

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific Exosome Detection and Diagnosis Introduction

11.1.4 Thermo Fisher Scientific Revenue in Exosome Detection and Diagnosis Business (2019-2024)

11.1.5 Thermo Fisher Scientific Recent Development

11.2 Bio-Techne

11.2.1 Bio-Techne Company Detail

11.2.2 Bio-Techne Business Overview

11.2.3 Bio-Techne Exosome Detection and Diagnosis Introduction

11.2.4 Bio-Techne Revenue in Exosome Detection and Diagnosis Business (2019-2024)

11.2.5 Bio-Techne Recent Development

11.3 System Biosciences

11.3.1 System Biosciences Company Detail

11.3.2 System Biosciences Business Overview

11.3.3 System Biosciences Exosome Detection and Diagnosis Introduction

11.3.4 System Biosciences Revenue in Exosome Detection and Diagnosis Business (2019-2024)

11.3.5 System Biosciences Recent Development

11.4 QIAGEN

11.4.1 QIAGEN Company Detail

11.4.2 QIAGEN Business Overview

11.4.3 QIAGEN Exosome Detection and Diagnosis Introduction

11.4.4 QIAGEN Revenue in Exosome Detection and Diagnosis Business (2019-2024)

11.4.5 QIAGEN Recent Development

11.5 Lonza

11.5.1 Lonza Company Detail

11.5.2 Lonza Business Overview

11.5.3 Lonza Exosome Detection and Diagnosis Introduction

11.5.4 Lonza Revenue in Exosome Detection and Diagnosis Business (2019-2024)

11.5.5 Lonza Recent Development

11.6 NX Pharmagen

11.6.1 NX Pharmagen Company Detail

11.6.2 NX Pharmagen Business Overview

11.6.3 NX Pharmagen Exosome Detection and Diagnosis Introduction

11.6.4 NX Pharmagen Revenue in Exosome Detection and Diagnosis Business (2019-2024)

11.6.5 NX Pharmagen Recent Development

11.7 NanoSomiX

11.7.1 NanoSomiX Company Detail

11.7.2 NanoSomiX Business Overview

11.7.3 NanoSomiX Exosome Detection and Diagnosis Introduction

11.7.4 NanoSomiX Revenue in Exosome Detection and Diagnosis Business (2019-2024)

11.7.5 NanoSomiX Recent Development

11.8 Miltenyi Biotech

11.8.1 Miltenyi Biotech Company Detail

11.8.2 Miltenyi Biotech Business Overview

11.8.3 Miltenyi Biotech Exosome Detection and Diagnosis Introduction

11.8.4 Miltenyi Biotech Revenue in Exosome Detection and Diagnosis Business (2019-2024)

11.8.5 Miltenyi Biotech Recent Development

11.9 Norgen Biotek

11.9.1 Norgen Biotek Company Detail

11.9.2 Norgen Biotek Business Overview

11.9.3 Norgen Biotek Exosome Detection and Diagnosis Introduction

11.9.4 Norgen Biotek Revenue in Exosome Detection and Diagnosis Business (2019-2024)

11.9.5 Norgen Biotek Recent Development

11.10 AMSBio

11.10.1 AMSBio Company Detail

11.10.2 AMSBio Business Overview

11.10.3 AMSBio Exosome Detection and Diagnosis Introduction

11.10.4 AMSBio Revenue in Exosome Detection and Diagnosis Business (2019-2024)

11.10.5 AMSBio Recent Development

11.11 Aethlon Medical

11.11.1 Aethlon Medical Company Detail

11.11.2 Aethlon Medical Business Overview

11.11.3 Aethlon Medical Exosome Detection and Diagnosis Introduction

11.11.4 Aethlon Medical Revenue in Exosome Detection and Diagnosis Business (2019-2024)

11.11.5 Aethlon Medical Recent Development

11.12 Anjarium Biosciences

11.12.1 Anjarium Biosciences Company Detail

11.12.2 Anjarium Biosciences Business Overview

11.12.3 Anjarium Biosciences Exosome Detection and Diagnosis Introduction

11.12.4 Anjarium Biosciences Revenue in Exosome Detection and Diagnosis Business (2019-2024)

11.12.5 Anjarium Biosciences Recent Development

11.13 Ciloa

11.13.1 Ciloa Company Detail

11.13.2 Ciloa Business Overview

11.13.3 Ciloa Exosome Detection and Diagnosis Introduction

11.13.4 Ciloa Revenue in Exosome Detection and Diagnosis Business (2019-2024)

11.13.5 Ciloa Recent Development

11.14 InnovaPrep

11.14.1 InnovaPrep Company Detail

11.14.2 InnovaPrep Business Overview

11.14.3 InnovaPrep Exosome Detection and Diagnosis Introduction

11.14.4 InnovaPrep Revenue in Exosome Detection and Diagnosis Business (2019-2024)

11.14.5 InnovaPrep Recent Development

11.15 Creative Medical Technologies

11.15.1 Creative Medical Technologies Company Detail

11.15.2 Creative Medical Technologies Business Overview

11.15.3 Creative Medical Technologies Exosome Detection and Diagnosis Introduction

11.15.4 Creative Medical Technologies Revenue in Exosome Detection and Diagnosis Business (2019-2024)

11.15.5 Creative Medical Technologies Recent Development

11.16 ILIAS Biologics

11.16.1 ILIAS Biologics Company Detail

11.16.2 ILIAS Biologics Business Overview

11.16.3 ILIAS Biologics Exosome Detection and Diagnosis Introduction

11.16.4 ILIAS Biologics Revenue in Exosome Detection and Diagnosis Business (2019-2024)

11.16.5 ILIAS Biologics Recent Development

11.17 Unchained Labs

11.17.1 Unchained Labs Company Detail

11.17.2 Unchained Labs Business Overview

11.17.3 Unchained Labs Exosome Detection and Diagnosis Introduction

11.17.4 Unchained Labs Revenue in Exosome Detection and Diagnosis Business (2019-2024)

11.17.5 Unchained Labs Recent Development

11.18 Rion

11.18.1 Rion Company Detail

11.18.2 Rion Business Overview

11.18.3 Rion Exosome Detection and Diagnosis Introduction

11.18.4 Rion Revenue in Exosome Detection and Diagnosis Business (2019-2024)

11.18.5 Rion Recent Development

11.19 Cell Guidance System

11.19.1 Cell Guidance System Company Detail

11.19.2 Cell Guidance System Business Overview

11.19.3 Cell Guidance System Exosome Detection and Diagnosis Introduction

11.19.4 Cell Guidance System Revenue in Exosome Detection and Diagnosis Business (2019-2024)

11.19.5 Cell Guidance System Recent Development

11.20 INOVIQ

11.20.1 INOVIQ Company Detail

11.20.2 INOVIQ Business Overview

11.20.3 INOVIQ Exosome Detection and Diagnosis Introduction

11.20.4 INOVIQ Revenue in Exosome Detection and Diagnosis Business (2019-2024)

11.20.5 INOVIQ Recent Development

11.21 Danaher

11.21.1 Danaher Company Detail

11.21.2 Danaher Business Overview

11.21.3 Danaher Exosome Detection and Diagnosis Introduction

11.21.4 Danaher Revenue in Exosome Detection and Diagnosis Business (2019-2024)

11.21.5 Danaher Recent Development

11.22 Exopharm

11.22.1 Exopharm Company Detail

11.22.2 Exopharm Business Overview

11.22.3 Exopharm Exosome Detection and Diagnosis Introduction

11.22.4 Exopharm Revenue in Exosome Detection and Diagnosis Business (2019-2024)

11.22.5 Exopharm Recent Development

11.23 Everzom

11.23.1 Everzom Company Detail

11.23.2 Everzom Business Overview

11.23.3 Everzom Exosome Detection and Diagnosis Introduction

11.23.4 Everzom Revenue in Exosome Detection and Diagnosis Business (2019-2024)

11.23.5 Everzom Recent Development

11.24 RoosterBio

11.24.1 RoosterBio Company Detail

11.24.2 RoosterBio Business Overview

11.24.3 RoosterBio Exosome Detection and Diagnosis Introduction

11.24.4 RoosterBio Revenue in Exosome Detection and Diagnosis Business (2019-2024)

11.24.5 RoosterBio Recent Development

11.25 Creative Biolabs

11.25.1 Creative Biolabs Company Detail

11.25.2 Creative Biolabs Business Overview

11.25.3 Creative Biolabs Exosome Detection and Diagnosis Introduction

11.25.4 Creative Biolabs Revenue in Exosome Detection and Diagnosis Business (2019-2024)

11.25.5 Creative Biolabs Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Exosome Detection and Diagnosis Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

    Table 2. Key Players of Kits & Reagents

    Table 3. Key Players of Instruments

    Table 4. Key Players of Services

    Table 5. Global Exosome Detection and Diagnosis Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

    Table 6. Global Exosome Detection and Diagnosis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 7. Global Exosome Detection and Diagnosis Market Size by Region (2019-2024) & (US$ Million)

    Table 8. Global Exosome Detection and Diagnosis Market Share by Region (2019-2024)

    Table 9. Global Exosome Detection and Diagnosis Forecasted Market Size by Region (2025-2030) & (US$ Million)

    Table 10. Global Exosome Detection and Diagnosis Market Share by Region (2025-2030)

    Table 11. Exosome Detection and Diagnosis Market Trends

    Table 12. Exosome Detection and Diagnosis Market Drivers

    Table 13. Exosome Detection and Diagnosis Market Challenges

    Table 14. Exosome Detection and Diagnosis Market Restraints

    Table 15. Global Exosome Detection and Diagnosis Revenue by Players (2019-2024) & (US$ Million)

    Table 16. Global Exosome Detection and Diagnosis Market Share by Players (2019-2024)

    Table 17. Global Top Exosome Detection and Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Detection and Diagnosis as of 2023)

    Table 18. Ranking of Global Top Exosome Detection and Diagnosis Companies by Revenue (US$ Million) in 2023

    Table 19. Global 5 Largest Players Market Share by Exosome Detection and Diagnosis Revenue (CR5 and HHI) & (2019-2024)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Exosome Detection and Diagnosis Product Solution and Service

    Table 22. Date of Enter into Exosome Detection and Diagnosis Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Exosome Detection and Diagnosis Market Size by Type (2019-2024) & (US$ Million)

    Table 25. Global Exosome Detection and Diagnosis Revenue Market Share by Type (2019-2024)

    Table 26. Global Exosome Detection and Diagnosis Forecasted Market Size by Type (2025-2030) & (US$ Million)

    Table 27. Global Exosome Detection and Diagnosis Revenue Market Share by Type (2025-2030)

    Table 28. Global Exosome Detection and Diagnosis Market Size by Application (2019-2024) & (US$ Million)

    Table 29. Global Exosome Detection and Diagnosis Revenue Market Share by Application (2019-2024)

    Table 30. Global Exosome Detection and Diagnosis Forecasted Market Size by Application (2025-2030) & (US$ Million)

    Table 31. Global Exosome Detection and Diagnosis Revenue Market Share by Application (2025-2030)

    Table 32. North America Exosome Detection and Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 33. North America Exosome Detection and Diagnosis Market Size by Country (2019-2024) & (US$ Million)

    Table 34. North America Exosome Detection and Diagnosis Market Size by Country (2025-2030) & (US$ Million)

    Table 35. Europe Exosome Detection and Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 36. Europe Exosome Detection and Diagnosis Market Size by Country (2019-2024) & (US$ Million)

    Table 37. Europe Exosome Detection and Diagnosis Market Size by Country (2025-2030) & (US$ Million)

    Table 38. Asia-Pacific Exosome Detection and Diagnosis Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 39. Asia-Pacific Exosome Detection and Diagnosis Market Size by Region (2019-2024) & (US$ Million)

    Table 40. Asia-Pacific Exosome Detection and Diagnosis Market Size by Region (2025-2030) & (US$ Million)

    Table 41. Latin America Exosome Detection and Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 42. Latin America Exosome Detection and Diagnosis Market Size by Country (2019-2024) & (US$ Million)

    Table 43. Latin America Exosome Detection and Diagnosis Market Size by Country (2025-2030) & (US$ Million)

    Table 44. Middle East & Africa Exosome Detection and Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 45. Middle East & Africa Exosome Detection and Diagnosis Market Size by Country (2019-2024) & (US$ Million)

    Table 46. Middle East & Africa Exosome Detection and Diagnosis Market Size by Country (2025-2030) & (US$ Million)

    Table 47. Thermo Fisher Scientific Company Detail

    Table 48. Thermo Fisher Scientific Business Overview

    Table 49. Thermo Fisher Scientific Exosome Detection and Diagnosis Product

    Table 50. Thermo Fisher Scientific Revenue in Exosome Detection and Diagnosis Business (2019-2024) & (US$ Million)

    Table 51. Thermo Fisher Scientific Recent Development

    Table 52. Bio-Techne Company Detail

    Table 53. Bio-Techne Business Overview

    Table 54. Bio-Techne Exosome Detection and Diagnosis Product

    Table 55. Bio-Techne Revenue in Exosome Detection and Diagnosis Business (2019-2024) & (US$ Million)

    Table 56. Bio-Techne Recent Development

    Table 57. System Biosciences Company Detail

    Table 58. System Biosciences Business Overview

    Table 59. System Biosciences Exosome Detection and Diagnosis Product

    Table 60. System Biosciences Revenue in Exosome Detection and Diagnosis Business (2019-2024) & (US$ Million)

    Table 61. System Biosciences Recent Development

    Table 62. QIAGEN Company Detail

    Table 63. QIAGEN Business Overview

    Table 64. QIAGEN Exosome Detection and Diagnosis Product

    Table 65. QIAGEN Revenue in Exosome Detection and Diagnosis Business (2019-2024) & (US$ Million)

    Table 66. QIAGEN Recent Development

    Table 67. Lonza Company Detail

    Table 68. Lonza Business Overview

    Table 69. Lonza Exosome Detection and Diagnosis Product

    Table 70. Lonza Revenue in Exosome Detection and Diagnosis Business (2019-2024) & (US$ Million)

    Table 71. Lonza Recent Development

    Table 72. NX Pharmagen Company Detail

    Table 73. NX Pharmagen Business Overview

    Table 74. NX Pharmagen Exosome Detection and Diagnosis Product

    Table 75. NX Pharmagen Revenue in Exosome Detection and Diagnosis Business (2019-2024) & (US$ Million)

    Table 76. NX Pharmagen Recent Development

    Table 77. NanoSomiX Company Detail

    Table 78. NanoSomiX Business Overview

    Table 79. NanoSomiX Exosome Detection and Diagnosis Product

    Table 80. NanoSomiX Revenue in Exosome Detection and Diagnosis Business (2019-2024) & (US$ Million)

    Table 81. NanoSomiX Recent Development

    Table 82. Miltenyi Biotech Company Detail

    Table 83. Miltenyi Biotech Business Overview

    Table 84. Miltenyi Biotech Exosome Detection and Diagnosis Product

    Table 85. Miltenyi Biotech Revenue in Exosome Detection and Diagnosis Business (2019-2024) & (US$ Million)

    Table 86. Miltenyi Biotech Recent Development

    Table 87. Norgen Biotek Company Detail

    Table 88. Norgen Biotek Business Overview

    Table 89. Norgen Biotek Exosome Detection and Diagnosis Product

    Table 90. Norgen Biotek Revenue in Exosome Detection and Diagnosis Business (2019-2024) & (US$ Million)

    Table 91. Norgen Biotek Recent Development

    Table 92. AMSBio Company Detail

    Table 93. AMSBio Business Overview

    Table 94. AMSBio Exosome Detection and Diagnosis Product

    Table 95. AMSBio Revenue in Exosome Detection and Diagnosis Business (2019-2024) & (US$ Million)

    Table 96. AMSBio Recent Development

    Table 97. Aethlon Medical Company Detail

    Table 98. Aethlon Medical Business Overview

    Table 99. Aethlon Medical Exosome Detection and Diagnosis Product

    Table 100. Aethlon Medical Revenue in Exosome Detection and Diagnosis Business (2019-2024) & (US$ Million)

    Table 101. Aethlon Medical Recent Development

    Table 102. Anjarium Biosciences Company Detail

    Table 103. Anjarium Biosciences Business Overview

    Table 104. Anjarium Biosciences Exosome Detection and Diagnosis Product

    Table 105. Anjarium Biosciences Revenue in Exosome Detection and Diagnosis Business (2019-2024) & (US$ Million)

    Table 106. Anjarium Biosciences Recent Development

    Table 107. Ciloa Company Detail

    Table 108. Ciloa Business Overview

    Table 109. Ciloa Exosome Detection and Diagnosis Product

    Table 110. Ciloa Revenue in Exosome Detection and Diagnosis Business (2019-2024) & (US$ Million)

    Table 111. Ciloa Recent Development

    Table 112. InnovaPrep Company Detail

    Table 113. InnovaPrep Business Overview

    Table 114. InnovaPrep Exosome Detection and Diagnosis Product

    Table 115. InnovaPrep Revenue in Exosome Detection and Diagnosis Business (2019-2024) & (US$ Million)

    Table 116. InnovaPrep Recent Development

    Table 117. Creative Medical Technologies Company Detail

    Table 118. Creative Medical Technologies Business Overview

    Table 119. Creative Medical Technologies Exosome Detection and Diagnosis Product

    Table 120. Creative Medical Technologies Revenue in Exosome Detection and Diagnosis Business (2019-2024) & (US$ Million)

    Table 121. Creative Medical Technologies Recent Development

    Table 122. ILIAS Biologics Company Detail

    Table 123. ILIAS Biologics Business Overview

    Table 124. ILIAS Biologics Exosome Detection and Diagnosis Product

    Table 125. ILIAS Biologics Revenue in Exosome Detection and Diagnosis Business (2019-2024) & (US$ Million)

    Table 126. ILIAS Biologics Recent Development

    Table 127. Unchained Labs Company Detail

    Table 128. Unchained Labs Business Overview

    Table 129. Unchained Labs Exosome Detection and Diagnosis Product

    Table 130. Unchained Labs Revenue in Exosome Detection and Diagnosis Business (2019-2024) & (US$ Million)

    Table 131. Unchained Labs Recent Development

    Table 132. Rion Company Detail

    Table 133. Rion Business Overview

    Table 134. Rion Exosome Detection and Diagnosis Product

    Table 135. Rion Revenue in Exosome Detection and Diagnosis Business (2019-2024) & (US$ Million)

    Table 136. Rion Recent Development

    Table 137. Cell Guidance System Company Detail

    Table 138. Cell Guidance System Business Overview

    Table 139. Cell Guidance System Exosome Detection and Diagnosis Product

    Table 140. Cell Guidance System Revenue in Exosome Detection and Diagnosis Business (2019-2024) & (US$ Million)

    Table 141. Cell Guidance System Recent Development

    Table 142. INOVIQ Company Detail

    Table 143. INOVIQ Business Overview

    Table 144. INOVIQ Exosome Detection and Diagnosis Product

    Table 145. INOVIQ Revenue in Exosome Detection and Diagnosis Business (2019-2024) & (US$ Million)

    Table 146. INOVIQ Recent Development

    Table 147. Danaher Company Detail

    Table 148. Danaher Business Overview

    Table 149. Danaher Exosome Detection and Diagnosis Product

    Table 150. Danaher Revenue in Exosome Detection and Diagnosis Business (2019-2024) & (US$ Million)

    Table 151. Danaher Recent Development

    Table 152. Exopharm Company Detail

    Table 153. Exopharm Business Overview

    Table 154. Exopharm Exosome Detection and Diagnosis Product

    Table 155. Exopharm Revenue in Exosome Detection and Diagnosis Business (2019-2024) & (US$ Million)

    Table 156. Exopharm Recent Development

    Table 157. Everzom Company Detail

    Table 158. Everzom Business Overview

    Table 159. Everzom Exosome Detection and Diagnosis Product

    Table 160. Everzom Revenue in Exosome Detection and Diagnosis Business (2019-2024) & (US$ Million)

    Table 161. Everzom Recent Development

    Table 162. RoosterBio Company Detail

    Table 163. RoosterBio Business Overview

    Table 164. RoosterBio Exosome Detection and Diagnosis Product

    Table 165. RoosterBio Revenue in Exosome Detection and Diagnosis Business (2019-2024) & (US$ Million)

    Table 166. RoosterBio Recent Development

    Table 167. Creative Biolabs Company Detail

    Table 168. Creative Biolabs Business Overview

    Table 169. Creative Biolabs Exosome Detection and Diagnosis Product

    Table 170. Creative Biolabs Revenue in Exosome Detection and Diagnosis Business (2019-2024) & (US$ Million)

    Table 171. Creative Biolabs Recent Development

    Table 172. Research Programs/Design for This Report

    Table 173. Key Data Information from Secondary Sources

    Table 174. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Exosome Detection and Diagnosis Market Size Comparison by Type (2024-2030) & (US$ Million)

    Figure 2. Global Exosome Detection and Diagnosis Market Share by Type: 2023 VS 2030

    Figure 3. Kits & Reagents Features

    Figure 4. Instruments Features

    Figure 5. Services Features

    Figure 6. Global Exosome Detection and Diagnosis Market Size Comparison by Application (2024-2030) & (US$ Million)

    Figure 7. Global Exosome Detection and Diagnosis Market Share by Application: 2023 VS 2030

    Figure 8. Cancers Case Studies

    Figure 9. Neurodegenerative Diseases Case Studies

    Figure 10. Cardiovascular Diseases Case Studies

    Figure 11. Infectious Diseases Case Studies

    Figure 12. Other Case Studies

    Figure 13. Exosome Detection and Diagnosis Report Years Considered

    Figure 14. Global Exosome Detection and Diagnosis Market Size (US$ Million), Year-over-Year: 2019-2030

    Figure 15. Global Exosome Detection and Diagnosis Market Size, (US$ Million), 2019 VS 2023 VS 2030

    Figure 16. Global Exosome Detection and Diagnosis Market Share by Region: 2023 VS 2030

    Figure 17. Global Exosome Detection and Diagnosis Market Share by Players in 2023

    Figure 18. Global Top Exosome Detection and Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Detection and Diagnosis as of 2023)

    Figure 19. The Top 10 and 5 Players Market Share by Exosome Detection and Diagnosis Revenue in 2023

    Figure 20. North America Exosome Detection and Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 21. North America Exosome Detection and Diagnosis Market Share by Country (2019-2030)

    Figure 22. United States Exosome Detection and Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 23. Canada Exosome Detection and Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 24. Europe Exosome Detection and Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 25. Europe Exosome Detection and Diagnosis Market Share by Country (2019-2030)

    Figure 26. Germany Exosome Detection and Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 27. France Exosome Detection and Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 28. U.K. Exosome Detection and Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 29. Italy Exosome Detection and Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 30. Russia Exosome Detection and Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 31. Nordic Countries Exosome Detection and Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 32. Asia-Pacific Exosome Detection and Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 33. Asia-Pacific Exosome Detection and Diagnosis Market Share by Region (2019-2030)

    Figure 34. China Exosome Detection and Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 35. Japan Exosome Detection and Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 36. South Korea Exosome Detection and Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 37. Southeast Asia Exosome Detection and Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 38. India Exosome Detection and Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 39. Australia Exosome Detection and Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 40. Latin America Exosome Detection and Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 41. Latin America Exosome Detection and Diagnosis Market Share by Country (2019-2030)

    Figure 42. Mexico Exosome Detection and Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 43. Brazil Exosome Detection and Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 44. Middle East & Africa Exosome Detection and Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 45. Middle East & Africa Exosome Detection and Diagnosis Market Share by Country (2019-2030)

    Figure 46. Turkey Exosome Detection and Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 47. Saudi Arabia Exosome Detection and Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Exosome Detection and Diagnosis Business (2019-2024)

    Figure 49. Bio-Techne Revenue Growth Rate in Exosome Detection and Diagnosis Business (2019-2024)

    Figure 50. System Biosciences Revenue Growth Rate in Exosome Detection and Diagnosis Business (2019-2024)

    Figure 51. QIAGEN Revenue Growth Rate in Exosome Detection and Diagnosis Business (2019-2024)

    Figure 52. Lonza Revenue Growth Rate in Exosome Detection and Diagnosis Business (2019-2024)

    Figure 53. NX Pharmagen Revenue Growth Rate in Exosome Detection and Diagnosis Business (2019-2024)

    Figure 54. NanoSomiX Revenue Growth Rate in Exosome Detection and Diagnosis Business (2019-2024)

    Figure 55. Miltenyi Biotech Revenue Growth Rate in Exosome Detection and Diagnosis Business (2019-2024)

    Figure 56. Norgen Biotek Revenue Growth Rate in Exosome Detection and Diagnosis Business (2019-2024)

    Figure 57. AMSBio Revenue Growth Rate in Exosome Detection and Diagnosis Business (2019-2024)

    Figure 58. Aethlon Medical Revenue Growth Rate in Exosome Detection and Diagnosis Business (2019-2024)

    Figure 59. Anjarium Biosciences Revenue Growth Rate in Exosome Detection and Diagnosis Business (2019-2024)

    Figure 60. Ciloa Revenue Growth Rate in Exosome Detection and Diagnosis Business (2019-2024)

    Figure 61. InnovaPrep Revenue Growth Rate in Exosome Detection and Diagnosis Business (2019-2024)

    Figure 62. Creative Medical Technologies Revenue Growth Rate in Exosome Detection and Diagnosis Business (2019-2024)

    Figure 63. ILIAS Biologics Revenue Growth Rate in Exosome Detection and Diagnosis Business (2019-2024)

    Figure 64. Unchained Labs Revenue Growth Rate in Exosome Detection and Diagnosis Business (2019-2024)

    Figure 65. Rion Revenue Growth Rate in Exosome Detection and Diagnosis Business (2019-2024)

    Figure 66. Cell Guidance System Revenue Growth Rate in Exosome Detection and Diagnosis Business (2019-2024)

    Figure 67. INOVIQ Revenue Growth Rate in Exosome Detection and Diagnosis Business (2019-2024)

    Figure 68. Danaher Revenue Growth Rate in Exosome Detection and Diagnosis Business (2019-2024)

    Figure 69. Exopharm Revenue Growth Rate in Exosome Detection and Diagnosis Business (2019-2024)

    Figure 70. Everzom Revenue Growth Rate in Exosome Detection and Diagnosis Business (2019-2024)

    Figure 71. RoosterBio Revenue Growth Rate in Exosome Detection and Diagnosis Business (2019-2024)

    Figure 72. Creative Biolabs Revenue Growth Rate in Exosome Detection and Diagnosis Business (2019-2024)

    Figure 73. Bottom-up and Top-down Approaches for This Report

    Figure 74. Data Triangulation

    Figure 75. Key Executives Interviewed